Rasmussen's syndrome treated with anakinra.

Arcan, Abdullah; Kizilkiliç, Esra Koçhan; Gündüz, Aysegül; Unkun, Rümeysa; Vezzani, Annamaria; Özkara, Çigdem

Arcan, Abdullah; Kizilkiliç, Esra Koçhan; Gündüz, Aysegül; Unkun, Rümeysa; Vezzani, Annamaria; Özkara, Çigdem.

Afiliação

Arcan A; Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Kizilkiliç EK; Department of Neurology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey. dr.kochanesra@gmail.com.
Gündüz A; Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Unkun R; Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Vezzani A; Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Özkara Ç; Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

J Neurol ; 271(2): 723-726, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37922068

Assuntos

Epilepsia Resistente a Medicamentos; Encefalite; Masculino; Humanos; Adulto; Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico; Espasmo; Interleucina-1; Paresia; Imageamento por Ressonância Magnética

Palavras-chave

Anakinra; Epilepsia Partialis Continua; Immunotherapy; Interleukin-1; Rasmussen's encephalitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalite / Epilepsia Resistente a Medicamentos Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google